12bit 5Gsps silicon proven High performance Current Steering DAC IP Core
Imagination pulls out of RISC-V CPUs
By Nick Flaherty, eeNews Europe (January 7, 2025)
Imagination Technology in the UK has shut down its development of RISC-V processor cores to focus on its GPU and AI products.
“Imagination exited its standalone line of CPUs to increase our investment in graphics, AI and compute at the edge which we believe is transformational for our business,” it told eeNews Europe. “We remain committed to the RISC-V ecosystem and believe this change to our business allows us to partner more easily with the wider ecosystem as providers of the GPU of choice for RISC-V.”
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
Related News
- Green Hills Software adds support for production-ready RTOS and tools to Imagination Technologies' RISC-V CPUs
- Baya Systems, Imagination Technologies and Andes Technology to Present on Heterogeneous Compute Architectures at Andes RISC-V CON Silicon Valley
- Andes Technology and Imagination Technologies Showcase Android 15 on High-Performance RISC-V Based Platform
- ESWIN Computing Pairs SiFive CPU, Imagination GPU and In House NPU in Latest RISC-V Edge Computing SoC
- Imagination's new Catapult CPU is driving RISC-V device adoption
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design